4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000138
Director sold 1,032 shares at an average $80.26 ($82,833)
- Director acquired 1,032 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
LOSCALZO JOSEPH · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +832 | $38.06 | $31,666 | 37,162 | D |
| 2026-03-03 | Sale : show line 2 in the form 10b5-1 | −832 | $80.33 | $66,833 | 36,330 | D |
| 2026-03-04 | Exercise or conversion : show line 3 in the form 10b5-1 | +200 | $38.06 | $7,612 | 36,530 | D |
| 2026-03-04 | Sale : show line 4 in the form 10b5-1 | −200 | $80.00 | $16,000 | 36,330 | D |
| Open-market sales · 1,032 sh · avg $80.26 · $82,833 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −832 | 11,168 | D |
| 2026-03-04 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −200 | 10,968 | D |
Loading xslF345X05/edgardoc.xml…